Glass House Brands Lands NYSE Listing, As Cannabis Industry Enters New Era

By Jelena Martinovic, Featured Writer

Glass House Brands Inc. (CBOE CA: GLAS.A.U) (OTCQX: GLASF) announced on Thursday that its subordinate voting shares have been approved for listing on the New York Stock Exchange (NYSE).

What Happened

The shares are expected to begin trading on the NYSE under the ticker “GLAS” on Tuesday, June 30, 2026, the company said in a press release.

The move follows the recent reclassification of medical cannabis to Schedule III under the Controlled Substances Act (CSA).

Why It Matters

CEO, chairman, and co-founder Kyle Kazan described the listing as a major milestone for the company, the cannabis industry, and long-term shareholders.

“This listing was not possible before the recent reclassification of medical cannabis to Schedule III and represents an important developmental milestone for Glass House, the cannabis industry overall, and our valued long-term shareholders who have supported us since inception,” Kyle Kazan, co-founder, chairman, and CEO of Glass House, said.

The rescheduling could create vast opportunities for cannabis businesses, including potential interstate cannabis commerce in the U.S., medical cannabis exports to Europe, expansion of the company’s addressable market and improved profitability and cash flow, according to the Glass House Brands’ management.

Moreover, the NYSE listing increases Glass House’s visibility and access to a broader investor base.

What’s Next

Glass House Brands expects its shares to keep trading on the OTCQX under the ticker GLASF until the close of trading on June 29, 2026.

The shares will also remain listed on CBOE Canada under the symbol GLAS.A.U.